{
    "ticker": "CRBP",
    "name": "Corbus Pharmaceuticals Holdings, Inc.",
    "description": "Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare and serious diseases. Founded in 2014 and headquartered in Norwood, Massachusetts, Corbus is committed to advancing drug candidates that target the endocannabinoid system to address unmet medical needs. The company\u2019s lead product candidate, lenabasum, is designed to treat serious autoimmune and fibrotic diseases. Lenabasum is currently being evaluated in multiple clinical trials for indications such as systemic sclerosis, dermatomyositis, and cystic fibrosis. Corbus is also exploring other therapeutic areas and drug candidates that leverage its proprietary drug delivery platform. The company emphasizes a patient-centric approach, striving to improve the quality of life for patients suffering from chronic conditions. Through its innovative research and development efforts, Corbus aims to deliver breakthrough therapies that can transform treatment paradigms in the pharmaceutical industry.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Norwood, Massachusetts, USA",
    "founded": "2014",
    "website": "https://www.corbuspharma.com",
    "ceo": "Yuval Cohen, Ph.D.",
    "social_media": {
        "twitter": "https://twitter.com/CorbusPharma",
        "linkedin": "https://www.linkedin.com/company/corbus-pharmaceuticals-holdings-inc/"
    },
    "investor_relations": "https://ir.corbuspharma.com",
    "key_executives": [
        {
            "name": "Yuval Cohen, Ph.D.",
            "position": "CEO"
        },
        {
            "name": "David K. G. K. K. H. D. F. L. A. M. R. D. E. S. M. G.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "Lenabasum"
            ]
        }
    ],
    "seo": {
        "meta_title": "Corbus Pharmaceuticals Holdings, Inc. | Innovative Therapeutics for Rare Diseases",
        "meta_description": "Explore Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company dedicated to developing novel treatments for rare and serious diseases.",
        "keywords": [
            "Corbus Pharmaceuticals",
            "Lenabasum",
            "Pharmaceuticals",
            "Biotechnology",
            "Rare Diseases",
            "Autoimmune Diseases"
        ]
    },
    "faq": [
        {
            "question": "What does Corbus Pharmaceuticals focus on?",
            "answer": "Corbus Pharmaceuticals focuses on developing novel therapeutics for rare and serious diseases."
        },
        {
            "question": "What is lenabasum?",
            "answer": "Lenabasum is Corbus's lead product candidate aimed at treating serious autoimmune and fibrotic diseases."
        },
        {
            "question": "Where is Corbus Pharmaceuticals headquartered?",
            "answer": "Corbus Pharmaceuticals is headquartered in Norwood, Massachusetts, USA."
        },
        {
            "question": "When was Corbus Pharmaceuticals founded?",
            "answer": "Corbus Pharmaceuticals was founded in 2014."
        }
    ],
    "competitors": [
        "VRTX",
        "AGIO",
        "SAGE",
        "MRNA"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "JNJ"
    ]
}